Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 2NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Squamous Cell Carcinoma of Head and Neck 41Head and Neck Neoplasms 41Uterine Cervical Neoplasms 31Lung Neoplasms 28Carcinoma, Non-Small-Cell Lung 23Ovarian Neoplasms 16Urinary Bladder Neoplasms 14Stomach Neoplasms 12Carcinoma, Ovarian Epithelial 12Sarcoma 9Neuroblastoma 9Esophageal Neoplasms 9Fallopian Tube Neoplasms 8Medulloblastoma 7Endometrial Neoplasms 7Biliary Tract Neoplasms 7Adenocarcinoma of Lung 7Adenocarcinoma Of Esophagus 7Teratoma 6Central Nervous System Neoplasms 6Brain Neoplasms 6Radiation Injuries 5Neoplasm Metastasis 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma 5Esophageal Squamous Cell Carcinoma 5Brenner Tumor 5Anus Neoplasms 5Urethral Neoplasms 4Testicular Neoplasms 4

Interventions

Vincristine 2Prednisone 2Gemcitabine 2Cyclophosphamide 2liposomal amphotericin B 1ixabepilone 1imetelstat 1Watchful Waiting 1VAP-cyclo protocol 1Rituximab 1Radiotherapy 1Palliative Care 1Nutritional Support 1Nicotine 1Moxifloxacin 1Morphine 1Lapatinib 1Everolimus 1Doxorubicin 1Dextromethorphan 1Dexamethasone 1Cytarabine 1Cyclosporins 1Cyclosporine 1Cisplatin 1Ciprofloxacin 1Celecoxib 1Caspofungin 1Analgesia 1Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Immunoblastic Lymphadenopathy × Cisplatin × Clear all
NCT00078949 2023-08-23

Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Canadian Cancer Trials Group

Phase 3 Completed
849 enrolled 13 charts
Lymphoid

Burkitt Lymphoma, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡